The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero. [electronic resource]
Producer: 20200203ISSN:- 2050-084X
- Alcohol Drinking -- adverse effects
- Animals
- Bumetanide -- administration & dosage
- Cerebral Cortex -- drug effects
- Disease Models, Animal
- Female
- Fetal Alcohol Spectrum Disorders -- physiopathology
- GABAergic Neurons -- drug effects
- Mice
- Prefrontal Cortex -- drug effects
- Pregnancy
- Pregnancy Complications -- physiopathology
- Sodium Potassium Chloride Symporter Inhibitors -- administration & dosage
- Solute Carrier Family 12, Member 2 -- metabolism
- Treatment Outcome
- gamma-Aminobutyric Acid -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.